Vivani Medical (VANI) Net Shares Issued and Repurchased (2014 - 2026)
Vivani Medical (VANI) posted Net Shares Issued and Repurchased of $227.0 for Q1 2026, down 99.99% on a QoQ basis from $1.9 million in Q4 2025, and down 99.91% year-over-year from $256215.0 in Q1 2025.
Analysis
Vivani Medical (VANI) Net Shares Issued and Repurchased (2014 - 2026) Analysis & Trends
Vivani Medical has reported Net Shares Issued and Repurchased for 13 years, with the latest figure at $227.0 in Q1 2026.
- On a quarterly basis, Net Shares Issued and Repurchased fell 99.91% year-over-year to $227.0 in Q1 2026; TTM through Mar 2026 was $227.0, a 99.91% decrease from a year earlier, with the FY2025 full-year figure at $1.9 million, up 72.1% from the prior year.
- Net Shares Issued and Repurchased was $227.0 for Q1 2026 at Vivani Medical, down from $1.9 million in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $1.9 million in Q4 2025, with the low at $2.0 in Q1 2022.
- Average Net Shares Issued and Repurchased over 5 years is $660217.6, with a median of $402500.0 recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Net Shares Issued and Repurchased sank 99.99% in 2022, then surged 20124900.0% in 2023.
- Over 5 years, Net Shares Issued and Repurchased stood at $866000.0 in 2022, then surged by 59.82% to $1.4 million in 2023, then declined by 21.03% to $1.1 million in 2024, then jumped by 72.1% to $1.9 million in 2025, then plunged by 99.99% to $227.0 in 2026.
- The last three Net Shares Issued and Repurchased figures came in at $227.0 (Q1 2026), $1.9 million (Q4 2025), and $256215.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | - |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | - |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -3.07 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | Vivani Medical | 109.30 Mn | 89.40 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 227.00 |
| Dec 31, 2025 | 1.88 Mn |
| Mar 31, 2025 | 256,215.00 |
| Dec 31, 2024 | 1.09 Mn |
| Mar 31, 2024 | 59,014.00 |
| Dec 31, 2023 | 1.38 Mn |
| Mar 31, 2023 | 402,500.00 |
| Dec 31, 2022 | 866,000.00 |
| Mar 31, 2022 | 2.00 |
| Dec 31, 2021 | 875,000.00 |
| Mar 31, 2021 | 14,000.00 |
| Dec 31, 2020 | 1.02 Mn |
| Sep 30, 2020 | 71,000.00 |
| Jun 30, 2020 | 586,000.00 |
| Mar 31, 2020 | 300,000.00 |
| Dec 31, 2019 | 336,000.00 |
| Mar 31, 2019 | 2.10 Mn |
| Dec 31, 2018 | 397,000.00 |
| Mar 31, 2018 | 2.34 Mn |
| Dec 31, 2017 | 2.70 Mn |